Literature DB >> 26495797

The 10 Pillars of Lung Cancer Screening: Rationale and Logistics of a Lung Cancer Screening Program.

Florian J Fintelmann1, Adam Bernheim1, Subba R Digumarthy1, Inga T Lennes1, Mannudeep K Kalra1, Matthew D Gilman1, Amita Sharma1, Efren J Flores1, Victorine V Muse1, Jo-Anne O Shepard1.   

Abstract

On the basis of the National Lung Screening Trial data released in 2011, the U.S. Preventive Services Task Force made lung cancer screening (LCS) with low-dose computed tomography (CT) a public health recommendation in 2013. The Centers for Medicare and Medicaid Services (CMS) currently reimburse LCS for asymptomatic individuals aged 55-77 years who have a tobacco smoking history of at least 30 pack-years and who are either currently smoking or had quit less than 15 years earlier. Commercial insurers reimburse the cost of LCS for individuals aged 55-80 years with the same smoking history. Effective care for the millions of Americans who qualify for LCS requires an organized step-wise approach. The 10-pillar model reflects the elements required to support a successful LCS program: eligibility, education, examination ordering, image acquisition, image review, communication, referral network, quality improvement, reimbursement, and research frontiers. Examination ordering can be coupled with decision support to ensure that only eligible individuals undergo LCS. Communication of results revolves around the Lung Imaging Reporting and Data System (Lung-RADS) from the American College of Radiology. Lung-RADS is a structured decision-oriented reporting system designed to minimize the rate of false-positive screening examination results. With nodule size and morphology as discriminators, Lung-RADS links nodule management pathways to the variety of nodules present on LCS CT studies. Tracking of patient outcomes is facilitated by a CMS-approved national registry maintained by the American College of Radiology. Online supplemental material is available for this article. (©)RSNA, 2015.

Entities:  

Mesh:

Year:  2015        PMID: 26495797     DOI: 10.1148/rg.2015150079

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  25 in total

1.  Effect of travel distance and rurality of residence on initial surveillance for hepatocellular carcinoma in VA primary care patient with cirrhosis.

Authors:  Yolanda Rodriguez Villalvazo; Jennifer S McDanel; Lauren A Beste; Antonio J Sanchez; Mary Vaughan-Sarrazin; David A Katz
Journal:  Health Serv Res       Date:  2019-11-25       Impact factor: 3.402

2.  Integrated, Multidisciplinary Management of Pulmonary Nodules Can Streamline Care and Improve Adherence to Recommendations.

Authors:  Thomas J Roberts; Inga T Lennes; Saif Hawari; Lecia V Sequist; Elyse R Park; Henning Willers; Angela Frank; Henning Gaissert; Jo-Anne Shepard; David Ryan
Journal:  Oncologist       Date:  2019-12-26

3.  Changes in Physician Knowledge, Attitudes, Beliefs, and Practices regarding Lung Cancer Screening.

Authors:  Louise M Henderson; Thad S Benefield; S Caitlin Bearden; Daniel S Reuland; Alison T Brenner; Adam O Goldstein; Allison Throneburg; M Patricia Rivera
Journal:  Ann Am Thorac Soc       Date:  2019-08

4.  Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in Europe.

Authors:  Jesper Holst Pedersen; Witold Rzyman; Giulia Veronesi; Thomas A D'Amico; Paul Van Schil; Laureano Molins; Gilbert Massard; Gaetano Rocco
Journal:  Eur J Cardiothorac Surg       Date:  2017-03-01       Impact factor: 4.191

Review 5.  Implementation and organization of lung cancer screening.

Authors:  Jesper Holst Pedersen; Haseem Ashraf
Journal:  Ann Transl Med       Date:  2016-04

Review 6.  Smoking cessation and lung cancer screening.

Authors:  Jesper Holst Pedersen; Philip Tønnesen; Haseem Ashraf
Journal:  Ann Transl Med       Date:  2016-04

7.  Underreporting of Interstitial Lung Abnormalities on Lung Cancer Screening Computed Tomography.

Authors:  Justin M Oldham; Ayodeji Adegunsoye; Satinderpal Khera; Elyse Lafond; Imre Noth; Mary E Strek; Michael Kadoch; Jonathan H Chung
Journal:  Ann Am Thorac Soc       Date:  2018-06

Review 8.  Risk assessment in relation to the detection of small pulmonary nodules.

Authors:  John K Field; Michael W Marcus; Matthijs Oudkerk
Journal:  Transl Lung Cancer Res       Date:  2017-02

Review 9.  Risk factors assessment and risk prediction models in lung cancer screening candidates.

Authors:  Mariusz Adamek; Ewa Wachuła; Sylwia Szabłowska-Siwik; Agnieszka Boratyn-Nowicka; Damian Czyżewski
Journal:  Ann Transl Med       Date:  2016-04

10.  Uniform Nomenclature to Describe Clinical Features of Pigmented Lesions.

Authors:  Kelsey S Flood; Gary J Martin; June K Robinson
Journal:  JAMA Dermatol       Date:  2017-10-01       Impact factor: 10.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.